Strong Equity PositionA strong equity position provides a financial cushion, enhancing the company's ability to withstand economic fluctuations and invest in growth opportunities.

High Gross Profit MarginMaintaining a high gross profit margin suggests efficient cost management and pricing power, which are crucial for long-term profitability as revenues recover.

Improved Debt LevelsReduced debt levels improve financial flexibility and reduce interest burden, allowing more resources to be allocated towards strategic initiatives and growth.

Bears Say

Declining RevenuesA consistent decline in revenues indicates challenges in market demand or competitive positioning, which can hinder long-term growth and profitability.

Negative Cash FlowSustained negative cash flow can strain financial resources, necessitating external funding and potentially limiting the company's ability to invest in growth.

Operational InefficienciesOperational inefficiencies can lead to higher costs and reduced profitability, impacting the company's ability to compete effectively and achieve sustainable growth.

FLUO FAQ

What was FluoGuide A/S’s price range in the past 12 months?

FluoGuide A/S lowest stock price was kr29.10 and its highest was kr48.50 in the past 12 months.

What is FluoGuide A/S’s market cap?

FluoGuide A/S’s market cap is kr454.91M.

When is FluoGuide A/S’s upcoming earnings report date?

FluoGuide A/S’s upcoming earnings report date is Feb 25, 2026 which is in 5 days.

How were FluoGuide A/S’s earnings last quarter?

FluoGuide A/S released its earnings results on Nov 27, 2025. The company reported -kr0.937 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.937.

Is FluoGuide A/S overvalued?

According to Wall Street analysts FluoGuide A/S’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does FluoGuide A/S pay dividends?

FluoGuide A/S does not currently pay dividends.

What is FluoGuide A/S’s EPS estimate?

FluoGuide A/S’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does FluoGuide A/S have?

FluoGuide A/S has 13,620,149 shares outstanding.

What happened to FluoGuide A/S’s price movement after its last earnings report?

FluoGuide A/S reported an EPS of -kr0.937 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.857%.

Which hedge fund is a major shareholder of FluoGuide A/S?

Currently, no hedge funds are holding shares in SE:FLUO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

FluoGuide A/S

FluoGuide A/S, a life science company, engages in the development and sale of surgical solutions in Denmark. Its lead product candidate is FG001, which is in Phase I/II for the treatment of high-grade glioma, as well as Phase II clinical trial for the treatment of lung cancer. The company also develops FG002, which is in preclinical stage that allows surgeons to differentiate cancer from normal tissue during surgery through a novel uPAR-targeted luminescent technology. FluoGuide A/S has an agreement with Linköping University Hospital for the development of FG001 that is in the Phase I/II clinical trial for surgical removal of brain cancer; and a collaboration with Copenhagen University Hospital. The company was incorporated in 2018 and is headquartered in Copenhagen, Denmark.